Examkin

Question

Difficulty: Very hardMedical History Evaluation

During morning rounds on the medical ward, a physician evaluates a 59-year-old woman who was admitted overnight for high fever, profound fatigue, and painful mouth sores. The patient reports that her symptoms started 4 days ago and have progressively worsened, accompanied by a noticeable decrease in urine output.

Her past medical history is notable for seropositive rheumatoid arthritis, which has been well-controlled for 4 years on a stable regimen of weekly methotrexate and daily folic acid (2 mg). She also has hypertension and type 2 diabetes mellitus, managed with lisinopril and metformin. Surgical history includes an uncomplicated cholecystectomy 10 years ago.

When taking a detailed interval history, the physician discovers several recent events. Six weeks ago, she traveled to rural Ohio to visit relatives and spent a day exploring local caves. Three weeks ago, seeking to 'boost her immune system', she began taking an over-the-counter echinacea extract. Two weeks ago, she developed dysuria and urinary frequency; she visited a local urgent care clinic and completed a 7-day course of trimethoprim-sulfamethoxazole, taking her last dose 5 days ago.

Vital signs are temperature 39.1°C (102.4°F), blood pressure 105/65 mm Hg, pulse 112/min, and respirations 18/min.

Physical examination is remarkable for extensive, coalescing, necrotic ulcerations on the buccal mucosa and soft palate. There is a diffuse petechial rash over the lower extremities. The abdomen is soft and non-tender without hepatosplenomegaly.

Laboratory results obtained on admission show:
Hemoglobin: 7.8 g/dL
Platelet count: 18,000/mm³
Leukocyte count: 1,200/mm³ (Absolute neutrophil count: 350/mm³)
Blood urea nitrogen: 52 mg/dL
Serum creatinine: 2.4 mg/dL (Baseline: 0.9 mg/dL)
Aspartate aminotransferase (AST): 210 U/L
Alanine aminotransferase (ALT): 195 U/L

Based on a meticulous evaluation of this patient's medical history, which of the following elements is the most direct cause of her current life-threatening presentation?

  1. A
    Spelunking exposure in the Ohio River Valley
  2. Recent course of trimethoprim-sulfamethoxazoleAnswer
  3. C
    Initiation of the over-the-counter echinacea extract
  4. D
    Long-standing history of type 2 diabetes mellitus
  5. E
    Prescribed regimen of prophylactic folic acid

Answer

The recent course of trimethoprim-sulfamethoxazole.
This patient's presentation of profound pancytopenia, severe oral mucositis, acute kidney injury, and hepatotoxicity is classic for acute methotrexate toxicity. Methotrexate is heavily cleared by renal tubular secretion and is highly protein-bound. Trimethoprim-sulfamethoxazole is contraindicated in patients taking methotrexate because sulfonamides displace methotrexate from plasma proteins and compete for renal tubular secretion, causing a sudden and massive increase in free serum methotrexate levels. Furthermore, trimethoprim and methotrexate have synergistic pharmacodynamic toxicity, as both inhibit dihydrofolate reductase. The acute onset of life-threatening bone marrow failure and mucositis following a course of this antibiotic is the hallmark of this severe pharmacokinetic and pharmacodynamic interaction.

Step-by-Step Solution

1
Analyze the patient's acute clinical presentation and laboratory findings.
The patient has severe pancytopenia, severe oral mucositis, acute kidney injury, and transaminitis.
Identifying the syndrome of multi-organ toxicity and bone marrow failure is the first step in formulating a differential diagnosis.
2
Evaluate the medical history for potential infectious versus iatrogenic etiologies.
The history contains competing risk factors: cave exploration in Ohio (risk for Histoplasmosis) versus recent administration of trimethoprim-sulfamethoxazole in a patient taking methotrexate.
Differentiating between an opportunistic infection and a severe adverse drug event is critical for accurate diagnosis and immediate management.
3
Correlate the specific timelines and physical findings with the risk factors.
The absence of hepatosplenomegaly makes disseminated histoplasmosis less likely. The timeline of finishing a sulfonamide 5 days prior perfectly aligns with acute methotrexate toxicity.
Trimethoprim-sulfamethoxazole displaces methotrexate from binding proteins and inhibits its renal clearance, precipitating life-threatening toxicity.

Key Concept

Patients taking methotrexate are at risk for life-threatening pancytopenia and mucositis if given trimethoprim-sulfamethoxazole, requiring meticulous medication history review.
Rate this question

Topics

Medical History Evaluation

More questions from this topic